These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 9269242)

  • 1. Growth hormone in end-stage heart failure.
    Wilmshurst P
    Lancet; 1997 Jun; 349(9068):1842-3. PubMed ID: 9269242
    [No Abstract]   [Full Text] [Related]  

  • 2. Growth hormone in end-stage heart failure.
    Khardori R; Taraben A; Taylor GJ; Falcone M
    Lancet; 1997 Jun; 349(9068):1842; author reply 1843. PubMed ID: 9269241
    [No Abstract]   [Full Text] [Related]  

  • 3. [Growth hormone and dilated cardiomyopathy].
    Dreifuss P
    Dtsch Med Wochenschr; 2002 Jun; 127(23):1261-3. PubMed ID: 12053286
    [No Abstract]   [Full Text] [Related]  

  • 4. Haemodynamic effects of amrinone infusion in patients with chronic heart failure.
    Manoharan S; Yadav BS; Tyagi S; Rao DK; Puri YK; Singh PP; Lochan R; Khalilullah M
    Indian Heart J; 1986; 38(5):362-6. PubMed ID: 3570319
    [No Abstract]   [Full Text] [Related]  

  • 5. [Intravenous molsidomine administration in heart failure. Part I: Dose-response relationship with reference to hemodynamic parameters].
    Störk T; Möckel M; Danne O; Müller R; Eichstädt H; Hochrein H
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():47-9. PubMed ID: 7968903
    [No Abstract]   [Full Text] [Related]  

  • 6. Growth hormone in end-stage heart failure.
    Dreifuss PM
    Lancet; 1997 Jun; 349(9068):1841-2; author reply 1843. PubMed ID: 9269240
    [No Abstract]   [Full Text] [Related]  

  • 7. [Intravenous molsidomine administration in heart failure. Part II: Comparison with nitroglycerin and effectiveness in nitrate tolerance].
    Störk T; Möckel M; Danne O; Müller R; Eichstädt H; Hochrein H
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():50-3. PubMed ID: 7968904
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparison of oral and intravenous administration of molsidomine in patients with heart failure].
    Grosse-Heitmeyer W; Huber T; Grewe R
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():54-7. PubMed ID: 7968905
    [No Abstract]   [Full Text] [Related]  

  • 9. Symptomatic hemodynamic and hormonal effects of intravenous captopril in patients with heart failure.
    Wu H; Zhao HY
    Chin Med J (Engl); 1994 May; 107(5):342-6. PubMed ID: 7924573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute hemodynamic effects of intravenous administration of molsidomine in secondary pulmonary hypertension and right heart failure].
    Jahed MM
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():58-61. PubMed ID: 7968906
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemodynamic effects of sodium nitroprusside in infants and children with large ventricular septal defect.
    Kunathai S; Ayuthya PS
    Pediatr Cardiol; 1989; 10(1):59. PubMed ID: 2704657
    [No Abstract]   [Full Text] [Related]  

  • 12. Haemodynamic effects of intravenous growth hormone in congestive heart failure.
    Volterrani M; Desenzani P; Lorusso R; d'Aloia A; Manelli F; Giustina A
    Lancet; 1997 Apr; 349(9058):1067-8. PubMed ID: 9107247
    [No Abstract]   [Full Text] [Related]  

  • 13. Reverse left ventricular remodeling by intermittent dobutamine infusions and amiodarone in end-stage heart failure due to idiopathic dilated cardiomyopathy.
    Nanas JN; Tsagalou EP; Nanas SN; Terrovitis JV; Tsolakis EJ; Toumanidis S; Papazoglou PD; Alexopoulos GP; Kanakakis J; Anastasiou-Nana MI
    Int J Cardiol; 2006 Apr; 108(2):237-43. PubMed ID: 16183152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The hemodynamic effectiveness of molsidomine infusions in patients with acute coronary insufficiency].
    Krüger R; Grewe R
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():26-9. PubMed ID: 7968897
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effects of nitroglycerin on refractory congestive heart failure by intravenous infusion].
    Ma S
    Zhonghua Xin Xue Guan Bing Za Zhi; 1992 Jun; 20(3):160-2, 195. PubMed ID: 1289026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertonic saline: a novel therapy for advanced heart failure?
    Drazner MH; Palmer BF
    Am Heart J; 2003 Mar; 145(3):377-9. PubMed ID: 12660656
    [No Abstract]   [Full Text] [Related]  

  • 17. Myocardial and vascular effects of intracoronary versus intravenous milrinone.
    Colucci WS; Ludmer PL; Wright RF; Arnold JM; Ganz P; Braunwald E
    Trans Assoc Am Physicians; 1985; 98():136-45. PubMed ID: 3842193
    [No Abstract]   [Full Text] [Related]  

  • 18. Myths and truths of growth hormone and testosterone therapy in heart failure.
    Nguyen CT; Aaronson A; Morrissey RP; Agarwal M; Willix RD; Schwarz ER
    Expert Rev Cardiovasc Ther; 2011 Jun; 9(6):711-20. PubMed ID: 21714602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Improved kidney function with intravenous prostaglandin E1 in patients with terminal heart failure].
    Wutte M; Hülsmann M; Berger R; Rödler S; Frey B; Stanek B; Pacher R
    Wien Klin Wochenschr; 1998 Jul; 110(13-14):473-8. PubMed ID: 9746960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ULTRAfiltration vs. DIureticS on clinical, biohumoral and haemodynamic variables in patients with deCOmpensated heart failure: the ULTRADISCO study.
    Giglioli C; Landi D; Cecchi E; Chiostri M; Gensini GF; Valente S; Ciaccheri M; Castelli G; Romano SM
    Eur J Heart Fail; 2011 Mar; 13(3):337-46. PubMed ID: 21131387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.